Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
1.410
-0.050 (-3.42%)
At close: Mar 28, 2025, 4:00 PM
1.417
+0.007 (0.48%)
After-hours: Mar 28, 2025, 7:50 PM EDT
Ironwood Pharmaceuticals Stock Forecast
IRWD's stock price has decreased by -83.64% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Ironwood Pharmaceuticals stock have an average target of 9.75, with a low estimate of 5.00 and a high estimate of 14. The average target predicts an increase of 591.49% from the current stock price of 1.41.
Analyst Consensus: Buy
* Price targets were last updated on Jan 30, 2025.
Analyst Ratings
The average analyst rating for Ironwood Pharmaceuticals stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Maintains $23 → $14 | Buy | Maintains | $23 → $14 | +892.91% | Jan 30, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +467.38% | Jan 22, 2025 |
| Leerink Partners | Leerink Partners | Hold Initiates $5 | Hold | Initiates | $5 | +254.61% | Sep 9, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $14 → $12 | Buy | Maintains | $14 → $12 | +751.06% | Aug 9, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $14 → $10 | Strong Buy | Maintains | $14 → $10 | +609.22% | Aug 9, 2024 |
Financial Forecast
Revenue This Year
292.71M
from 351.41M
Decreased by -16.70%
Revenue Next Year
323.46M
from 292.71M
Increased by 10.51%
EPS This Year
0.24
from 0.01
Increased by 2,260.28%
EPS Next Year
0.51
from 0.24
Increased by 114.92%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 394.6M | 560.9M | 768.8M | ||
| Avg | 292.7M | 323.5M | 424.1M | ||
| Low | 258.7M | 237.2M | 227.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.3% | 91.6% | 137.7% | ||
| Avg | -16.7% | 10.5% | 31.1% | ||
| Low | -26.4% | -19.0% | -29.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.41 | 1.18 | 2.07 | ||
| Avg | 0.24 | 0.51 | 1.22 | ||
| Low | 0.08 | 0.14 | 0.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3,995.0% | 398.2% | 307.8% | ||
| Avg | 2,260.3% | 114.9% | 141.3% | ||
| Low | 684.0% | -41.9% | 37.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.